(lp0
S"Here's Why ImmunoGen, Inc. Skyrocketed 45% in February Motley Fool - Mar 9, 2017 Shares of ImmunoGen , a small-cap biopharmaceutical company that utilizes its proprietary antibody-drug conjugate  technology to fight various forms of cancer, skyrocketed 45% during February, according to data from S&amp;P Global&nbsp;...The 4.5% Stake of ImmunoGen, Inc.  Owned by Primecap Management Company - DailyQuint"
p1
aS"Why ImmunoGen, Inc. Skyrocketed Higher Today Motley Fool - Feb 27, 2017 It's also possible investors are buying ahead of the Society of Gynecologic Oncology's Annual Meeting of Women's Cancer next month where ImmunoGen is scheduled to present additional phase 1 data from a subset of patients getting its cancer medication&nbsp;...ImmunoGen Inc  Has A Wave Of Catalysts About To Hit Press - Insider FinancialImmunoGen, Inc.  Update On Trial of Mirvetuximab Soravtansine - Journal Transcript"
p2
aS"3 Charts That Show the Potential Risks and Rewards for Immunogen, Inc. Stock Motley Fool - Mar 4, 2017 After 36 years of being in business, Immunogen  has yet to make a profit. Unfortunately, the biotech still isn't close to reaching break-even status."
p3
aS'ImmunoGen Inc.  Moves Higher on Volume Spike for March 14 Equities.com - Mar 14, 2017 ImmunoGen Inc.  traded on unusually high volume on Mar. 14, as the stock gained 1.57% to close at $3.88. On the day, ImmunoGen Inc. saw 3.75 million shares trade hands on 11,317 trades. Considering that the stock averages only a daily volume of&nbsp;...ImmunoGen, Inc.  Given Hold Rating at Cowen and Company - Chaffey BreezeWhy Analysts put forward these two stocks: ImmunoGen, Inc. , Rice Energy ... - The USA Commerce'
p4
aS'ImmunoGen Inc.  Moves Higher on Volume Spike for March 10 Equities.com - Mar 10, 2017 ImmunoGen Inc.  traded on unusually high volume on Mar. 10, as the stock gained 1.91% to close at $3.73. On the day, ImmunoGen Inc. saw 4.78 million shares trade hands on 14,569 trades. Considering that the stock averages only a daily volume of&nbsp;...Stock Showing Surging Activity: ImmunoGen, Inc.  - HugoPressWatch List: ImmunoGen, Inc.  , MCBC Holdings, Inc.  - NYSE Journal '
p5
aS'An End-of-Day Technical Review: ImmunoGen, Inc. , K2M Group Holdings ... Post Analyst - Mar 17, 2017 ImmunoGen, Inc.  has made its way to a 12-month decline of -49.93%. Turning to K2M Group Holdings, Inc. , its shares were trading at $19.43 a retreat of $-0.42, on the trading floor.'
p6
aS'Immunogen Inc.  PT Lowered to $1.30 at Morgan Stanley StreetInsider.com - Mar 1, 2017 Morgan Stanley lowered its price target on Immunogen Inc.  to $1.30  while maintaining a Underweight rating.ImmunoGen, Inc.  Lowered to Hold at Zacks Investment Research - The Cerbat Gem'
p7
aS'ImmunoGen, Inc.  Receives $5.54 Average Price Target from Brokerages The Cerbat Gem - Mar 17, 2017 ImmunoGen logo Shares of ImmunoGen, Inc.  have been given a consensus recommendation of Hold by the nine ratings firms that are currently covering the company.The Cowen and Company Reiterates Hold Rating for ImmunoGen, Inc.  - Petro Global News 24'
p8
aS"Option Market: ImmunoGen Inc Risk Hits An Unsually High Level CML News - Mar 15, 2017 We're going to look at a proprietary risk rating for the next 30-days built by Capital Market Laboratories  based on a large number of interactions of data points, many of which come directly from the option market for ImmunoGen Inc  ."
p9
aS'Stock Returns: BioSpecifics Technologies Corp.  versus ImmunoGen ... CML News - Mar 16, 2017 This is a snapshot to compare the stock returns for BioSpecifics Technologies Corp.  versus ImmunoGen Inc  .'
p10
a.